The role of fungi in C. difficile infection: An underappreciated transkingdom interaction

被引:16
|
作者
Stewart, David [1 ]
Romo, Jesus A. [2 ]
Lamendella, Regina [3 ]
Kumamoto, Carol A. [2 ]
机构
[1] Univ Arizona, Dept Surg, Tucson, AZ 85724 USA
[2] Tufts Univ, Dept Mol Biol & Microbiol, 150 Harrison Ave, Boston, MA 02111 USA
[3] Juniata Coll, Dept Biol, Huntingdon, PA 16652 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Mycobiome; Gastrointestinal tract; Infection; Clostridioides difficile; Candida albicans; CANDIDA-ALBICANS COLONIZATION; NECROTIZING ENTEROCOLITIS; MICROBIOTA; RESPONSES; GUT; INFLAMMATION; OVERGROWTH; MODULATION; INFANTIS;
D O I
10.1016/j.fgb.2019.04.007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Novel culture independent technologies have further elucidated the composition of the human mycobiome, though the role of fungi in human health and disease remains largely unknown. Recent studies have suggested conflicting roles for fungi in the gastrointestinal tract, underscoring the complexity of the interactions between the mycobiome, its bacterial counterpart, and the host. One key example is the observation that fungal taxa are overrepresented in patients with Clostridioides difficile infection (CDI), suggesting a role for fungi in this disease. Recent studies in murine models have demonstrated the ability of the commensal fungus Candida albicans to alter the course of CDI, supporting the notion that fungi play a role in this infection. This review summarizes current data on fungi and CDI, and shows that views of the dysbiotic state that is central to the pathogenesis of CDI are incomplete without consideration of the mycobiome.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Risk Factors and Outcome of C. difficile Infection after Hematopoietic Stem Cell Transplantation
    Rosignoli, Chiara
    Petruzzellis, Giuseppe
    Radici, Vera
    Facchin, Gabriele
    Girgenti, Marco
    Stella, Rossella
    Isola, Miriam
    Battista, Martalisa
    Sperotto, Alessandra
    Geromin, Antonella
    Cerno, Michela
    Arzese, Alessandra
    Deias, Paola
    Tascini, Carlo
    Fanin, Renato
    Patriarca, Francesca
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 15
  • [32] Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile
    Viala, Celine
    Le Monnier, Alban
    Maataoui, Naouale
    Rousseau, Clotilde
    Collignon, Anne
    Poilane, Isabelle
    JOURNAL OF MICROBIOLOGICAL METHODS, 2012, 90 (02) : 83 - 85
  • [33] C. difficile PCR-ribotype 023 might go undetected when using Chromld C. difficile agar
    Reigadas, E.
    Alcala, L.
    Marin, M.
    Martin, A.
    Bouza, E.
    ANAEROBE, 2017, 44 : 34 - 35
  • [34] Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
    Lee, Ching-Chi
    Lee, Jen-Chieh
    Chiu, Chun-Wei
    Tsai, Pei-Jane
    Ko, Wen-Chien
    Hung, Yuan-Pin
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [35] Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection
    Basseres, Eugenie
    Endres, Bradley T.
    Khaleduzzaman, Mohammed
    Miraftabi, Faranak
    Alam, M. Jahangir
    Vickers, Richard J.
    Garey, Kevin W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (05) : 1245 - 1251
  • [36] The effect of different C. difficile MLST strains on viability and activity of macrophages
    Saad, Gewa
    Azrad, Maya
    Aias, Meral
    Leshem, Tamar
    Hamo, Zohar
    Abu Rahmoun, Layan
    Peretz, Avi
    HELIYON, 2023, 9 (03)
  • [37] MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection
    Hong, Simon J.
    Feuerstadt, Paul
    Brandt, Lawrence J.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (02) : 275 - 280
  • [38] Prevention and treatment of C. difficile in cancer patients
    Puerta-Alcalde, Pedro
    Garcia-Vidal, Carolina
    Soriano, Alex
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (06) : 473 - 480
  • [39] Evaluation of cobas® Liat® Cdiff, STANDARD™ M10 C. difficile and Xpert® C. difficile BT assays for rapid detection of toxigenic Clostridioides difficile
    Suominen, Juulia
    Korhonen, Suvi
    Kutvonen, Heini
    Jarva, Hanna
    Patari-Sampo, Anu
    Loginov, Raisa
    JOURNAL OF MICROBIOLOGICAL METHODS, 2024, 226
  • [40] Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile
    Hughes, Jaime
    Aston, Carl
    Kelly, Michelle L.
    Griffin, Ruth
    PHARMACEUTICS, 2022, 14 (05)